The Zambia cholera vaccines market has been witnessing significant growth in recent years. Cholera vaccines help prevent cholera caused due to contaminated food or water. The disease is highly contagious and causes severe diarrhea and dehydration. The oral cholera vaccine is one of the commonly used vaccines against the disease. It provides around 60% effective protection against cholera. Increasing government support for distribution of oral cholera vaccines through public-private partnerships has augmented the uptake of these vaccines in Zambia in the recent past.

Zambia Cholera Vaccines Market is estimated to be valued at US$ 1.47 MN in 2024 and is expected to exhibit a CAGR of 14 % over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Zambia cholera vaccines market are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD, Johnson & Johnson Services Inc., Celldex Therapeutics. Biovac Inc. is one of the leading players manufacturing oral cholera vaccines for Zambia.

The demand for cholera vaccines is growing in Zambia due to rising awareness about the disease prevention. Public health programs by the government and non-profit organizations are educating people in remote areas about the importance of hygiene and vaccines.

Major Zambia Cholera Vaccines Market Size producers are expanding their presence in Africa to cater to the demand from countries like Zambia. Partnerships with local healthcare providers and supply chain players are helping them distribute vaccines more efficiently.

Market drivers

Increased focus on immunization programs: The Zambian government has identified cholera immunization as a priority area. It is working with global health agencies and donors to scale up the reach of oral cholera vaccination programs. This is driving the demand for cholera vaccines.

Impact of geopolitical situation on Zambia Cholera Vaccines market growth

The Zambia Cholera Vaccines market is heavily influenced by the geopolitical climate of the African continent. Ongoing conflicts and political instability in surrounding nations like the Democratic Republic of the Congo and Tanzania have contributed to increased refugee flows and disrupted trade routes. This has exacerbated the spread of infectious diseases like cholera across borders. Recent outbreaks in conflict-affected areas demonstrate how vulnerable populations lose access to clean water and sanitation facilities during times of strife, heightening infection risks. Moreover, allocation of public health resources tends to take a backseat amid security crises, weakening disease surveillance and response capabilities. The market must consider potential supply chain disruptions and volatility in demand from procurement agencies in rolling out production and distribution planning. Stockpiling of vaccines may become necessary to ensure preparedness for unexpected surges in disease incidence linked to geopolitical events. Regional cooperation on monitoring cross-border disease transmission and coordinated vaccination drives will also be important to curb future epidemics.